AdaptHealth Corp. (AHCO), a leading provider of home healthcare equipment and services, saw its stock price surge by 5.08% during intraday trading on Wednesday, February 26th, 2025. The company's strong performance can be attributed to its impressive fourth-quarter 2024 results and positive outlook for 2025, as highlighted in its recent earnings release.
In the fourth quarter of 2024, AdaptHealth reported flat revenue compared to the prior year quarter, but exceeded the midpoint of its guidance by 3%. The Sleep Health and Respiratory Health segments demonstrated year-over-year growth, with Sleep Health revenue increasing by 3.4% and Respiratory Health revenue rising by 1%. While the Diabetes Health segment experienced a 7.3% decline in revenue, the company's adjusted EBITDA and free cash flow exceeded the high end of its guidance ranges.
For the full year 2024, AdaptHealth achieved revenue of $3.26 billion, representing a 1.9% increase over the previous year. The company's adjusted EBITDA grew by 2.7% to $688.7 million, and its net leverage ratio improved to 2.8 times, thanks to a $170 million reduction in debt during the year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.